Search

everythinglearnresearchcommunity

for

Search:↓

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Finasteride interacts with terazosin, but not doxazosin; caution needed.

Androgens may influence bladder cancer progression by affecting cellular behavior.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Finasteride helps female-pattern hair loss.

New genes and pathways are important for testosterone production and male sexual development.

Higher DHT levels are linked to more acne in adolescents, especially boys.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Dutasteride helps reduce male pattern hair loss, but may cause side effects like altered libido and erectile dysfunction.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Simple methods using DHT levels effectively assess compliance.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.